Physicians' Academy for Cardiovascular Education

Current treatment of Diabetes in Heart Failure

10' education - May 21, 2016 - ESC HF 2016, Florence, Italy - Adriaan Voors, MD - UMCG Groningen, The Netherlands

Video navigation menu

  • HF and diabetes: a prevalent combination with poor prognosis 0:13
  • What the new ESC HF guidelines say about current anti-diabetic therapies in HF - insulin 2:18
  • Sulfonylureas should be used with caution 4:10
  • Metformin is safe and the treatment of choice in HF patients with diabetes 5:09
  • TZDs are not recommended in patients with HF 5:58
  • GLP-1 analogues and DPP4 inhibitors potentially increase risk, but safety data in HF is lacking 7:17
  • Overview of the ESC HF 2016 guideline recommendations on treatment of HF and diabetes 9:35

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: